之江生物取得一项医疗器械注册证

Core Viewpoint - Zhijiang Biotech (688317.SH) has recently obtained a Class III medical device registration certificate for its product, the novel coronavirus 2019-nCoV nucleic acid test kit (fluorescent PCR method) [1] Group 1 - The product is specifically designed for the detection of the novel coronavirus [1] - The registration certificate indicates compliance with national medical device regulations, enhancing the company's product portfolio [1] - This development may position the company favorably in the healthcare market, particularly in the context of ongoing pandemic responses [1]